TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Faruqi & Faruqi, Llp
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health

Securities law firm Faruqi & Faruqi is investigating potential claims against agilon health for allegedly making false and misleading statements about 2025 guidance and overstating financial benefits from strategic actions. The company suspended its full-year 2025 guidance on August 4, 2025, resulting in a 51.5% stock decline the following day. Investors who purchased securities between February 26 and August 4, 2025 are encouraged to contact the firm, with a March 2, 2026 deadline to seek lead plaintiff status.

Insights
AGL   negative

The company is the subject of a federal securities class action lawsuit alleging violations of securities laws through false and misleading statements about 2025 guidance and overstated financial impacts. The stock experienced a severe 51.5% decline following the suspension of guidance, indicating significant investor losses and loss of confidence in management's credibility.